z-logo
open-access-imgOpen Access
Role for Endovascular Therapy in Chronic Mesenteric Ischemia
Author(s) -
Romaric Loffroy,
Éric Steinmetz,
Boris Guiu,
Valérie Molin,
Bénjamin Kretz,
Alice Gagnaire,
Olivier Bouchot,
J.P. Cercueil,
R Brenot,
D. Krausé
Publication year - 2009
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2009/249840
Subject(s) - medicine , revascularization , percutaneous , mesenteric ischemia , surgery , abdominal pain , ischemia , stent , radiology , angioplasty , endovascular treatment , occlusion , stenosis , cardiology , aneurysm , myocardial infarction
Chronic mesenteric ischemia is a rare condition that is caused by stenosis or occlusion of the mesenteric arteries and usually manifests as abdominal pain. While surgical revascularization has been the standard treatment for symptomatic patients, recent advances in interventional devices and techniques have made endovascular treatment feasible and effective. Percutaneous transluminal angioplasty with stent placement is now recognized as a minimally invasive means of obtaining good long-term results with an acceptable recurrence rate; consequently, the technique is suggested for the primary treatment of chronic mesenteric ischemia. The present article discusses the indications and principles of endovascular treatment, and reviews the literature, with emphasis on short- and long-term outcomes, particularly morbidity and mortality rates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom